| Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus F Vincenti, S Friman, E Scheuermann, L Rostaing, T Jenssen, ... American Journal of Transplantation 7 (6), 1506-1514, 2007 | 759 | 2007 |
| Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on … JM Neuberger, WO Bechstein, DRJ Kuypers, P Burra, F Citterio, ... Transplantation 101 (4S), S1-S56, 2017 | 337 | 2017 |
| Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study HH Hirsch, F Vincenti, S Friman, M Tuncer, F Citterio, A Wiecek, ... American journal of transplantation 13 (1), 136-145, 2013 | 298 | 2013 |
| Everolimus with reduced calcineurin inhibitor exposure in renal transplantation J Pascual, SP Berger, O Witzke, H Tedesco, S Mulgaonkar, Y Qazi, ... Journal of the American Society of Nephrology 29 (7), 1979-1991, 2018 | 276 | 2018 |
| Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 P Piselli, D Serraino, GP Segoloni, S Sandrini, GB Piredda, MP Scolari, ... European Journal of Cancer 49 (2), 336-344, 2013 | 226 | 2013 |
| Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients R Ferguson, J Grinyó, F Vincenti, DB Kaufman, ES Woodle, BA Marder, ... American Journal of Transplantation 11 (1), 66-76, 2011 | 226 | 2011 |
| Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein E Rossi, LM Biasucci, F Citterio, S Pelliccioni, C Monaco, F Ginnetti, ... Circulation 105 (7), 800-803, 2002 | 204 | 2002 |
| Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature B Nashan, F Citterio Transplantation 94 (6), 547-561, 2012 | 179 | 2012 |
| Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe D Serraino, P Piselli, G Busnach, P Burra, F Citterio, E Arbustini, ... European Journal of Cancer 43 (14), 2117-2123, 2007 | 145 | 2007 |
| Pharmacokinetics for once-versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial Z Wlodarczyk, JP Squifflet, M Ostrowski, P Rigotti, S Stefoni, F Citterio, ... American Journal of Transplantation 9 (11), 2505-2513, 2009 | 141 | 2009 |
| Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study SP Berger, C Sommerer, O Witzke, H Tedesco, S Chadban, S Mulgaonkar, ... American Journal of Transplantation 19 (11), 3018-3034, 2019 | 140 | 2019 |
| Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients M Andreoni, D Goletti, P Pezzotti, A Pozzetto, P Monini, L Sarmati, ... Journal of Infection 43 (3), 195-199, 2001 | 134 | 2001 |
| Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial M Salvadori, MP Scolari, E Bertoni, F Citterio, P Rigotti, M Cossu, ... Transplantation 88 (10), 1194-1202, 2009 | 122 | 2009 |
| Prediction, prevention, and management of delayed graft function: where are we now? B Nashan, M Abbud‐Filho, F Citterio Clinical Transplantation 30 (10), 1198-1208, 2016 | 111 | 2016 |
| Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: an analysis from the randomized TRANSFORM study H Tedesco-Silva, J Pascual, O Viklicky, N Basic-Jukic, E Cassuto, DY Kim, ... Transplantation 103 (9), 1953-1963, 2019 | 95 | 2019 |
| Evolution of the therapeutic drug monitoring of cyclosporine F Citterio Transplantation proceedings 36 (2), S420-S425, 2004 | 95 | 2004 |
| Steroid side effects and their impact on transplantation outcome. F Citterio Transplantation 72 (12 Suppl), S75-80, 2001 | 94 | 2001 |
| Renal vein thrombosis after renal transplantation: an important cause of graft loss P Giustacchini, F Pisanti, F Citterio, AM De Gaetano, M Castagneto, ... Transplantation proceedings 34 (6), 2126-2127, 2002 | 93 | 2002 |
| ‘Old-for-old’—new strategies for renal transplantation W Arns, F Citterio, JM Campistol Nephrology Dialysis Transplantation 22 (2), 336-341, 2007 | 80 | 2007 |
| Gonadal function and immunosuppressive therapy after renal transplantation V Tondolo, F Citterio, N Panocchia, G Nanni, E Favi, A Brescia, ... Transplantation proceedings 37 (4), 1915-1917, 2005 | 71 | 2005 |
